Ankita Pramanick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ankita Pramanick has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Andrew C. Daly
CÚRAM, Research Ireland Centre for Medical Devices, University of Galway, Galway, Ireland
6 shared publications - Vasileios Sergis
CÚRAM Research Ireland Centre for Medical Devices University of Galway Galway H91 W2TY Ireland
5 shared publications - Daniel Kelly
CÚRAM, Research Ireland Centre for Medical Devices, University of Galway, Galway, Ireland
4 shared publications - Abhay Pandit
Cúram Research Ireland Centre for Medical Devices University of Galway Galway Ireland
3 shared publications Graham Britchfield
Biomedical Engineering, University of Galway, School of Engineering, University Road, Galway, Ireland, Galway, H91 TK33, IRELAND
2 shared publications- Karl Mason
University of Galway
2 shared publications
Latest Publications
- Open Access
- 20 May 2026
- Published by Wiley in Advanced Science
- Vol. 13 (45) , e22241
Developmentally Inspired Bioprinting of Nascent Multicellular Human Heart Tissue Through in Situ Differentiation and Morphogenesis of iPSCs
Current approaches to heart tissue bioprinting typically rely on using human induced pluripotent stem cell (iPSC)‐derived cardiomyocytes that are pre‐differentiated in 2D culture. This differs fundamentally from embryonic heart development, where mesodermal progenitors differentiate into cardiomyocytes within 3D, matrix‐rich, and shape‐morphing microenvironments. Here, we introduce a developmentally inspired approach that enables in situ mesodermal and cardiac differentiation of iPSCs within bioprinted, shape‐morphing pluripotent tissues. Using embedded bioprinting, Matrigel bioinks with high‐density iPSC suspensions were deposited into granular support hydrogels to generate pluripotent tissue constructs with defined architectures. These constructs exhibited shape‐morphing behavior, tunable by modulating the support bath viscoelasticity. Support bath mechanics also regulated iPSC fate, with softer formulations reducing spontaneous differentiation. Building on this, mesodermal and cardiac differentiation were directly driven within the morphing constructs via temporal WNT pathway modulation, resulting in multicellular cardiac tissues in which cardiomyocytes and fibroblasts co‐emerge from a common progenitor pool. These nascent heart tissues exhibited a developmental phenotype, with immunofluorescence and gene expression profiling revealing cardiac progenitors alongside maturing cardiomyocytes. Together, these findings highlight the potential for an alternative developmental biofabrication paradigm focused on printing pluripotent organ rudiments that recapitulate early aspects of embryonic development via programmed in situ lineage specification and shape‐morphing.
- 20 May 2026
- Published by Wiley in Advanced Science
- Vol. 13 (45) , e22241
Open AccessDevelopmentally Inspired Bioprinting of Nascent Multicellular Human Heart Tissue Through in Situ Differentiation and Morphogenesis of iPSCs
Current approaches to heart tissue bioprinting typically rely on using human induced pluripotent stem cell (iPSC)‐derived cardiomyocytes that are pre‐differentiated in 2D culture. This differs fundamentally from embryonic heart development, where mesodermal progenitors differentiate into cardiomyocytes within 3D, matrix‐rich, and shape‐morphing microenvironments. Here, we introduce a developmentally inspired approach that enables in situ mesodermal and cardiac differentiation of iPSCs within bioprinted, shape‐morphing pluripotent tissues. Using embedded bioprinting, Matrigel bioinks with high‐density iPSC suspensions were deposited into granular support hydrogels to generate pluripotent tissue constructs with defined architectures. These constructs exhibited shape‐morphing behavior, tunable by modulating the support bath viscoelasticity. Support bath mechanics also regulated iPSC fate, with softer formulations reducing spontaneous differentiation. Building on this, mesodermal and cardiac differentiation were directly driven within the morphing constructs via temporal WNT pathway modulation, resulting in multicellular cardiac tissues in which cardiomyocytes and fibroblasts co‐emerge from a common progenitor pool. These nascent heart tissues exhibited a developmental phenotype, with immunofluorescence and gene expression profiling revealing cardiac progenitors alongside maturing cardiomyocytes. Together, these findings highlight the potential for an alternative developmental biofabrication paradigm focused on printing pluripotent organ rudiments that recapitulate early aspects of embryonic development via programmed in situ lineage specification and shape‐morphing.
- Open Access
Developmentally inspired bioprinting of nascent multicellular human heart tissue through in situ differentiation and morphogenesis of iPSCs
Traditional heart tissue bioprinting typically relies on using human induced pluripotent stem cell (iPSC)-derived cardiomyocytes that are pre-differentiated in 2D culture. This approach differs fundamentally from embryonic heart development, where mesodermal progenitors differentiate into cardiomyocytes within 3D, matrix-rich, and shape-morphing microenvironments. Here, we introduce a novel developmentally inspired approach that enables in situ mesodermal and cardiac differentiation of iPSCs within bioprinted, shape-morphing pluripotent tissues. Using embedded bioprinting, Matrigel bioinks with high-density iPSC suspensions were deposited into granular support hydrogels to generate pluripotent tissue constructs with defined architectures. These constructs exhibited shape-morphing behaviour, tunable by modulating the support bath viscoelasticity. Support bath mechanics also regulated iPSC fate, with softer formulations reducing spontaneous differentiation. Building on this, mesodermal induction and cardiogenesis were directly driven within the morphing constructs via temporal WNT pathway modulation, resulting in multicellular cardiac tissues in which cardiomyocytes, fibroblasts, and endothelial cells co-emerge from a common progenitor pool. Importantly, these nascent tissues underwent structural maturation, with immunofluorescence and gene expression profiling revealing cardiac progenitors alongside maturing cardiomyocytes. Together, these findings highlight the potential for a new paradigm in biofabrication focused on printing pluripotent organ rudiments that recapitulate key aspects of embryonic development and support progressive tissue maturation.
Open AccessDevelopmentally inspired bioprinting of nascent multicellular human heart tissue through in situ differentiation and morphogenesis of iPSCs
Traditional heart tissue bioprinting typically relies on using human induced pluripotent stem cell (iPSC)-derived cardiomyocytes that are pre-differentiated in 2D culture. This approach differs fundamentally from embryonic heart development, where mesodermal progenitors differentiate into cardiomyocytes within 3D, matrix-rich, and shape-morphing microenvironments. Here, we introduce a novel developmentally inspired approach that enables in situ mesodermal and cardiac differentiation of iPSCs within bioprinted, shape-morphing pluripotent tissues. Using embedded bioprinting, Matrigel bioinks with high-density iPSC suspensions were deposited into granular support hydrogels to generate pluripotent tissue constructs with defined architectures. These constructs exhibited shape-morphing behaviour, tunable by modulating the support bath viscoelasticity. Support bath mechanics also regulated iPSC fate, with softer formulations reducing spontaneous differentiation. Building on this, mesodermal induction and cardiogenesis were directly driven within the morphing constructs via temporal WNT pathway modulation, resulting in multicellular cardiac tissues in which cardiomyocytes, fibroblasts, and endothelial cells co-emerge from a common progenitor pool. Importantly, these nascent tissues underwent structural maturation, with immunofluorescence and gene expression profiling revealing cardiac progenitors alongside maturing cardiomyocytes. Together, these findings highlight the potential for a new paradigm in biofabrication focused on printing pluripotent organ rudiments that recapitulate key aspects of embryonic development and support progressive tissue maturation.
- Open Access
Dityrosine photocrosslinking of native collagen bioinks for controlled shape-fidelity of bioprinted cardiac tissue constructs: probing the interplay between fibrillogenesis and covalent bond formation
Collagen bioinks are widely used in biofabrication, but their relatively soft mechanical properties can lead to structural instabilities under cell-generated contraction forces. While synthetic functional groups can be conjugated for covalent crosslinking, these methods often disrupt natural protein fibrillogenesis, thereby compromising collagen fibre architecture. This work presents a strategy for the direct covalent stabilisation of native collagen bioinks with dityrosine bonds via visible-light photocrosslinking with ruthenium (Ru) and sodium persulfate (SPS), avoiding the need for polymer pre-functionalisation. Multimodal characterisation, including high-resolution microscopy, spectroscopy, mass spectrometry, and nanoindentation, identified photocrosslinking conditions that enhance collagen fibrillogenesis and reduce off-target polymer oxidation. Interestingly, the biofabrication process itself affected ultimate collagen fibre architecture, with shear-induced alignment during extrusion enhancing fibril proximity and self-assembly, overcoming inhibitory effects the crosslinkers had on fibrillogenesis via ionic and electrostatic interactions. Leveraging these insights, embedded bioprinting was used to fabricate cardiac constructs with high cell viability (>80%), where dityrosine crosslinking could be tuned to modulate geometric shape changes under cell-generated forces (1-15% shrinkage). Finally, the platform was used to bioprint anatomically accurate double-ventricle human heart models with robust shape fidelity. This research establishes a versatile photocrosslinking framework for bioprinting cardiac constructs with tunable shape stability using native collagen bioinks.
Open AccessDityrosine photocrosslinking of native collagen bioinks for controlled shape-fidelity of bioprinted cardiac tissue constructs: probing the interplay between fibrillogenesis and covalent bond formation
Collagen bioinks are widely used in biofabrication, but their relatively soft mechanical properties can lead to structural instabilities under cell-generated contraction forces. While synthetic functional groups can be conjugated for covalent crosslinking, these methods often disrupt natural protein fibrillogenesis, thereby compromising collagen fibre architecture. This work presents a strategy for the direct covalent stabilisation of native collagen bioinks with dityrosine bonds via visible-light photocrosslinking with ruthenium (Ru) and sodium persulfate (SPS), avoiding the need for polymer pre-functionalisation. Multimodal characterisation, including high-resolution microscopy, spectroscopy, mass spectrometry, and nanoindentation, identified photocrosslinking conditions that enhance collagen fibrillogenesis and reduce off-target polymer oxidation. Interestingly, the biofabrication process itself affected ultimate collagen fibre architecture, with shear-induced alignment during extrusion enhancing fibril proximity and self-assembly, overcoming inhibitory effects the crosslinkers had on fibrillogenesis via ionic and electrostatic interactions. Leveraging these insights, embedded bioprinting was used to fabricate cardiac constructs with high cell viability (>80%), where dityrosine crosslinking could be tuned to modulate geometric shape changes under cell-generated forces (1-15% shrinkage). Finally, the platform was used to bioprint anatomically accurate double-ventricle human heart models with robust shape fidelity. This research establishes a versatile photocrosslinking framework for bioprinting cardiac constructs with tunable shape stability using native collagen bioinks.
- Open Access
- 28 January 2025
- Published by IOP Publishing in Biofabrication
- Vol. 17 (2) , 025004
In-situ quality monitoring during embedded bioprinting using integrated microscopy and classical computer vision
Despite significant advances in bioprinting technology, current hardware platforms lack the capability for process monitoring and quality control. This limitation hampers the translation of the technology into industrial GMP-compliant manufacturing settings. As a key step towards a solution, we developed a novel bioprinting platform integrating a high-resolution camera for in-situ monitoring of extrusion outcomes during embedded bioprinting. Leveraging classical computer vision and image analysis techniques, we then created a custom software module for assessing print quality. This module enables quantitative comparison of printer outputs to input points of the computer-aided design model’s 2D projections, measuring area and positional accuracy. To showcase the platform’s capabilities, we then investigated compatibility with various bioinks, dyes, and support bath materials for both 2D and 3D print path trajectories. In addition, we performed a detailed study on how the rheological properties of granular support hydrogels impact print quality during embedded bioprinting, illustrating a practical application of the platform. Our results demonstrated that lower viscosity, faster thixotropy recovery, and smaller particle sizes significantly enhance print fidelity. This novel bioprinting platform, equipped with integrated process monitoring, holds great potential for establishing auditable and more reproducible biofabrication processes for industrial applications.
- 28 January 2025
- Published by IOP Publishing in Biofabrication
- Vol. 17 (2) , 025004
Open AccessIn-situ quality monitoring during embedded bioprinting using integrated microscopy and classical computer vision
Despite significant advances in bioprinting technology, current hardware platforms lack the capability for process monitoring and quality control. This limitation hampers the translation of the technology into industrial GMP-compliant manufacturing settings. As a key step towards a solution, we developed a novel bioprinting platform integrating a high-resolution camera for in-situ monitoring of extrusion outcomes during embedded bioprinting. Leveraging classical computer vision and image analysis techniques, we then created a custom software module for assessing print quality. This module enables quantitative comparison of printer outputs to input points of the computer-aided design model’s 2D projections, measuring area and positional accuracy. To showcase the platform’s capabilities, we then investigated compatibility with various bioinks, dyes, and support bath materials for both 2D and 3D print path trajectories. In addition, we performed a detailed study on how the rheological properties of granular support hydrogels impact print quality during embedded bioprinting, illustrating a practical application of the platform. Our results demonstrated that lower viscosity, faster thixotropy recovery, and smaller particle sizes significantly enhance print fidelity. This novel bioprinting platform, equipped with integrated process monitoring, holds great potential for establishing auditable and more reproducible biofabrication processes for industrial applications.
- Open Access
- 24 November 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (5)
4D Bioprinting Shape‐Morphing Tissues in Granular Support Hydrogels: Sculpting Structure and Guiding Maturation
During embryogenesis, organs undergo dynamic shape transformations that sculpt their final shape, composition, and function. Despite this, current organ bioprinting approaches typically employ bioinks that restrict cell‐generated morphogenetic behaviors resulting in structurally static tissues. This work introduces a novel platform that enables the bioprinting of tissues that undergo programmable and predictable 4D shape‐morphing driven by cell‐generated forces. This method utilizes embedded bioprinting to deposit collagen‐hyaluronic acid bioinks within yield‐stress granular support hydrogels that can accommodate and regulate 4D shape‐morphing through their viscoelastic properties. Importantly, precise control over 4D shape‐morphing is possible by modulating factors such as the initial print geometry, cell phenotype, bioink composition, and support hydrogel viscoelasticity. Further, shape‐morphing is found to actively sculpt cell and extracellular matrix alignment along the principal tissue axis through a stress‐avoidance mechanism. To enable predictive design of 4D shape‐morphing patterns, a finite element model is developed that accurately captures shape evolution at both the cellular and tissue levels. Finally, it is demonstrated that programmed 4D shape‐morphing enhances the structural and functional properties of iPSC‐derived heart tissues. This ability to design, predict, and program 4D shape‐morphing holds great potential for engineering organ rudiments that recapitulate morphogenetic processes to sculpt their final shape, composition, and function.
- 24 November 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (5)
Open Access4D Bioprinting Shape‐Morphing Tissues in Granular Support Hydrogels: Sculpting Structure and Guiding Maturation
During embryogenesis, organs undergo dynamic shape transformations that sculpt their final shape, composition, and function. Despite this, current organ bioprinting approaches typically employ bioinks that restrict cell‐generated morphogenetic behaviors resulting in structurally static tissues. This work introduces a novel platform that enables the bioprinting of tissues that undergo programmable and predictable 4D shape‐morphing driven by cell‐generated forces. This method utilizes embedded bioprinting to deposit collagen‐hyaluronic acid bioinks within yield‐stress granular support hydrogels that can accommodate and regulate 4D shape‐morphing through their viscoelastic properties. Importantly, precise control over 4D shape‐morphing is possible by modulating factors such as the initial print geometry, cell phenotype, bioink composition, and support hydrogel viscoelasticity. Further, shape‐morphing is found to actively sculpt cell and extracellular matrix alignment along the principal tissue axis through a stress‐avoidance mechanism. To enable predictive design of 4D shape‐morphing patterns, a finite element model is developed that accurately captures shape evolution at both the cellular and tissue levels. Finally, it is demonstrated that programmed 4D shape‐morphing enhances the structural and functional properties of iPSC‐derived heart tissues. This ability to design, predict, and program 4D shape‐morphing holds great potential for engineering organ rudiments that recapitulate morphogenetic processes to sculpt their final shape, composition, and function.
- Open Access
In-situ quality monitoring during embedded bioprinting using integrated microscopy and classical computer vision
Despite significant advances in bioprinting technology, current hardware platforms lack the capability for process monitoring and quality control. This limitation hampers the translation of the technology into industrial GMP-compliant manufacturing settings. To address this, we developed a novel bioprinting platform integrating a high-resolution camera for in-situ monitoring of extrusion outcomes during embedded bioprinting. Leveraging classical computer vision and image analysis techniques, we then created a custom software module for assessing print quality. This module enables quantitative comparison of printer outputs to input CAD models, measuring area and positional accuracy. To showcase the platform’s capabilities, we then investigated how the rheological properties of granular support hydrogels impact print quality during embedded bioprinting. Our results demonstrated that lower viscosity, faster thixotropy recovery, and smaller particle sizes significantly enhance print fidelity. This novel bioprinting platform, equipped with integrated process monitoring, holds great potential for establishing robust, reliable, and auditable biofabrication processes for industrial applications.
Open AccessIn-situ quality monitoring during embedded bioprinting using integrated microscopy and classical computer vision
Despite significant advances in bioprinting technology, current hardware platforms lack the capability for process monitoring and quality control. This limitation hampers the translation of the technology into industrial GMP-compliant manufacturing settings. To address this, we developed a novel bioprinting platform integrating a high-resolution camera for in-situ monitoring of extrusion outcomes during embedded bioprinting. Leveraging classical computer vision and image analysis techniques, we then created a custom software module for assessing print quality. This module enables quantitative comparison of printer outputs to input CAD models, measuring area and positional accuracy. To showcase the platform’s capabilities, we then investigated how the rheological properties of granular support hydrogels impact print quality during embedded bioprinting. Our results demonstrated that lower viscosity, faster thixotropy recovery, and smaller particle sizes significantly enhance print fidelity. This novel bioprinting platform, equipped with integrated process monitoring, holds great potential for establishing robust, reliable, and auditable biofabrication processes for industrial applications.